Runimotamab

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Runimotamab, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers [Phase 1]